Spero Therapeutics, Inc.
FCF Per Share
| Fiscal Year | FCF Per Share | Cyclically Adjusted FCF Per Share |
|---|---|---|
| FY2020 | $-2.94 | $-3.33 |
| FY2021 | $-2.08 | $-3.15 |
| FY2022 | $-0.21 | $-2.66 |
| FY2023 | $-0.62 | $-2.37 |
| FY2024 | $-0.43 | $-2.13 |
FCF Per Share
| Fiscal Year | FCF Per Share | Cyclically Adjusted FCF Per Share |
|---|---|---|
| FY2020 | $-2.94 | $-3.33 |
| FY2021 | $-2.08 | $-3.15 |
| FY2022 | $-0.21 | $-2.66 |
| FY2023 | $-0.62 | $-2.37 |
| FY2024 | $-0.43 | $-2.13 |